Cannabis Watch: Curaleaf shares tumble 8% after FDA warning letter over CBD health claims

Shares of cannabis company Curaleaf Holdings Inc. slid 7% Tuesday, after the U.S. Food and Drug Administration issued a warning letter to the company for selling CBD-based products that it claims can treat serious diseases.